Correlation Between B Communications and Lineage Cell

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both B Communications and Lineage Cell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining B Communications and Lineage Cell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between B Communications and Lineage Cell Therapeutics, you can compare the effects of market volatilities on B Communications and Lineage Cell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in B Communications with a short position of Lineage Cell. Check out your portfolio center. Please also check ongoing floating volatility patterns of B Communications and Lineage Cell.

Diversification Opportunities for B Communications and Lineage Cell

-0.6
  Correlation Coefficient

Excellent diversification

The 3 months correlation between BCOM and Lineage is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding B Communications and Lineage Cell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lineage Cell Therapeutics and B Communications is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on B Communications are associated (or correlated) with Lineage Cell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lineage Cell Therapeutics has no effect on the direction of B Communications i.e., B Communications and Lineage Cell go up and down completely randomly.

Pair Corralation between B Communications and Lineage Cell

Assuming the 90 days trading horizon B Communications is expected to generate 0.48 times more return on investment than Lineage Cell. However, B Communications is 2.1 times less risky than Lineage Cell. It trades about 0.39 of its potential returns per unit of risk. Lineage Cell Therapeutics is currently generating about -0.21 per unit of risk. If you would invest  132,500  in B Communications on September 4, 2024 and sell it today you would earn a total of  38,600  from holding B Communications or generate 29.13% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

B Communications  vs.  Lineage Cell Therapeutics

 Performance 
       Timeline  
B Communications 

Risk-Adjusted Performance

24 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in B Communications are ranked lower than 24 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, B Communications sustained solid returns over the last few months and may actually be approaching a breakup point.
Lineage Cell Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Lineage Cell Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

B Communications and Lineage Cell Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with B Communications and Lineage Cell

The main advantage of trading using opposite B Communications and Lineage Cell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if B Communications position performs unexpectedly, Lineage Cell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lineage Cell will offset losses from the drop in Lineage Cell's long position.
The idea behind B Communications and Lineage Cell Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios